Search





Search





Markets
/
Stocks
/
inmb
/

INmune Bio Inc

INMB

Add to Watchlist

1.750USD

-0.020-1.13%

Close 07-31 16:00（ET）Quotes delayed by 15 min

46.52MMarket Cap

LossP/E TTM

INmune Bio Inc

1.750

-0.020-1.13%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-07-31

Previous score

3.00

Change

The current institutional shareholding score of INmune Bio Inc is 3.00, ranking 192 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 18.84%, representing a quarter-over-quarter increase of 8.44%. The largest institutional shareholder is ETHSX, holding a total of 22.09K shares, representing 0.10% of shares outstanding, with 0.00% increase in holdings.

Institutional Shareholding

Shareholder Activity

Name

Shares Held

Chg %

Lowdell (Mark William)

1.51M

Moss (David J.)

1.29M

BlackRock Institutional Trust Company, N.A.

1.12M

+1.60%

Geode Capital Management, L.L.C.

441.65K

-5.92%

State Street Investment Management (US)

347.26K

+22.35%

UBS Financial Services, Inc.

60.80K

-60.90%

Susquehanna International Group, LLP

250.91K

+59.86%

Raymond James Financial Services Advisors, Inc.

206.37K

-18.59%

Northern Trust Investments, Inc.

172.12K

-5.63%